Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α2-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine

Florence Serres; Mark J. Millan; Trevor Sharp

doi:10.1017/s1461145711000733

Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α2-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine

The International Journal of Neuropsychopharmacology ◽

10.1017/s1461145711000733 ◽

2011 ◽

Vol 15 (05) ◽

pp. 617-629 ◽

Cited By ~ 13

Author(s):

Florence Serres ◽

Mark J. Millan ◽

Trevor Sharp

Keyword(s):

Reuptake Inhibitor ◽

Antidepressant Treatment ◽

Rapid Response ◽

Molecular Adaptation ◽

The Novel ◽

Adrenoceptor Antagonist ◽

Α2 Adrenoceptor ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep–wake cycle architecture in the rat

Psychopharmacology ◽

10.1007/s00213-005-0016-5 ◽

2005 ◽

Vol 181 (4) ◽

pp. 639-652 ◽

Cited By ~ 12

Author(s):

Raymond Cespuglio ◽

Colette Rousset ◽

Gabriel Debilly ◽

Catherine Rochat ◽

Mark J. Millan

Keyword(s):

Reuptake Inhibitor ◽

Acute Administration ◽

The Novel ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

The novel antidepressant, S35966, is a mixed serotonin and noradrenaline reuptake inhibitor and an antagonist at α2-adrenoceptors

European Neuropsychopharmacology ◽

10.1016/s0924-977x(02)80316-9 ◽

2002 ◽

Vol 12 ◽

pp. 248 ◽

Cited By ~ 5

Author(s):

A. Gobert ◽

D. Cussac ◽

F. Lejeune ◽

A. Newman-Tancredi ◽

V. Audinot ◽

...

Keyword(s):

Reuptake Inhibitor ◽

The Novel ◽

Α2 Adrenoceptors ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Faculty Opinions recommendation of Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1058908.509706 ◽

2007 ◽

Author(s):

Paul Hilton

Keyword(s):

Systematic Review ◽

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Reuptake Inhibitor ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.4.7.1165 ◽

2003 ◽

Vol 4 (7) ◽

pp. 1165-1174 ◽

Cited By ~ 51

Author(s):

Christopher J Kratochvil ◽

Brigette S Vaughan ◽

Martin J Harrington ◽

William J Burke

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Reuptake Inhibitor ◽

Attention Deficit ◽

Hyperactivity Disorder ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

(R)-Sila-venlafaxine: A selective noradrenaline reuptake inhibitor for the treatment of emesis

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/j.bmcl.2005.12.062 ◽

2006 ◽

Vol 16 (9) ◽

pp. 2555-2558 ◽

Cited By ~ 37

Author(s):

Graham A. Showell ◽

Matthew J. Barnes ◽

Jürgen O. Daiss ◽

John S. Mills ◽

John G. Montana ◽

...

Keyword(s):

Reuptake Inhibitor ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

The effect of serotonin–noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats

European Spine Journal ◽

10.1007/s00586-015-4239-9 ◽

2015 ◽

Vol 25 (3) ◽

pp. 877-887 ◽

Cited By ~ 13

Author(s):

Junichi Handa ◽

Miho Sekiguchi ◽

Olga Krupkova ◽

Shin-ichi Konno

Keyword(s):

Reuptake Inhibitor ◽

Intervertebral Disk ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Serotonin and noradrenaline reuptake inhibitor duloxetine reduces daily off time in Parkinson’s disease

Journal of the Neurological Sciences ◽

10.1016/j.jns.2015.08.1012 ◽

2015 ◽

Vol 357 ◽

pp. e291

Author(s):

M. Tomiyama ◽

Y. Funamizu ◽

T. Kon ◽

T. Ueno ◽

H. Nishijima ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Reuptake Inhibitor ◽

Noradrenaline Reuptake ◽

Off Time ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Efficacy and safety of the noradrenaline reuptake inhibitor, TAS‐303, in women with stress urinary incontinence: Results of a double‐blind, randomized, placebo‐controlled, early phase II trial

International Journal of Urology ◽

10.1111/iju.14411 ◽

2020 ◽

Author(s):

Satoru Takahashi ◽

Kumiko Kato ◽

Mineo Takei ◽

Osamu Yokoyama ◽

Momokazu Gotoh

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Phase Ii ◽

Reuptake Inhibitor ◽

Early Phase ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

The discovery of 071031B, a novel serotonin and noradrenaline reuptake inhibitor

Neuroscience Letters ◽

10.1016/j.neulet.2013.02.076 ◽

2013 ◽

Vol 544 ◽

pp. 68-73 ◽

Cited By ~ 14

Author(s):

Rui Xue ◽

Yan-Ping Zhang ◽

Zeng-Liang Jin ◽

Li Yuan ◽

Xin-Hua He ◽

...

Keyword(s):

Reuptake Inhibitor ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Sila-venlafaxine, a Sila-Analogue of the Serotonin/Noradrenaline Reuptake Inhibitor Venlafaxine: Synthesis, Crystal Structure Analysis, and Pharmacological Characterization

Organometallics ◽

10.1021/om058051y ◽

2006 ◽

Vol 25 (5) ◽

pp. 1188-1198 ◽

Cited By ~ 54

Author(s):

Jürgen O. Daiss ◽

Christian Burschka ◽

John S. Mills ◽

John G. Montana ◽

Graham A. Showell ◽

...

Keyword(s):

Crystal Structure ◽

Structure Analysis ◽

Reuptake Inhibitor ◽

Crystal Structure Analysis ◽

Pharmacological Characterization ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text